The latest research shows that myoferlin regulates cancer‐derived exosomes and functions as a new player in exosome biology.41 As mentioned above, myoferlin impacts tumour‐associated angiogenesis by affecting VEGFA secretion and EGFR activity.36, 66 These findings suggest that myoferlin induces the malignant phenotype of cancers by altering the tumour microenvironment. Here, EGFR is linked to cancer.